Statera BioPharma (STU:7CB) Dividend Payout Ratio : 0.00 (As of Sep. 2022)

View and export this data going back to 2021. Start your Free Trial

What is Statera BioPharma Dividend Payout Ratio?

Statera BioPharma's dividend payout ratio for the months ended in Sep. 2022 was 0.00.

The historical rank and industry rank for Statera BioPharma's Dividend Payout Ratio or its related term are showing as below:

STU:7CB's Dividend Payout Ratio is not ranked ^*
in the Biotechnology industry.
Industry Median: 0.435
* Ranked among companies with meaningful Dividend Payout Ratio only.

As of today (2024-06-24), the Dividend Yield % of Statera BioPharma is 0.00%.

Statera BioPharma's Dividends per Share for the months ended in Sep. 2022 was €0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Statera BioPharma Dividend Payout Ratio Historical Data

The historical data trend for Statera BioPharma's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Statera BioPharma Dividend Payout Ratio Chart

Statera BioPharma Annual Data

Trend

Dec19

Dec20

Dec21

Dividend Payout Ratio

Statera BioPharma Quarterly Data
	Dec19	Mar20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
Dividend Payout Ratio	Get a 7-Day Free Trial						-	-	-	-	-

Competitive Comparison of Statera BioPharma's Dividend Payout Ratio

For the Biotechnology subindustry, Statera BioPharma's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Statera BioPharma's Dividend Payout Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Statera BioPharma's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Statera BioPharma's Dividend Payout Ratio falls into.

Statera BioPharma Dividend Payout Ratio Calculation

Dividend payout ratio measures the percentage of the company's earnings paid out as dividends.

Statera BioPharma's Dividend Payout Ratio for the fiscal year that ended in Dec. 2021 is calculated as

Dividend Payout Ratio	=	Dividends per Share (A: Dec. 2021 )	/	EPS without NRI (A: Dec. 2021 )
	=	0	/	-0.853
	=	N/A

Statera BioPharma's Dividend Payout Ratio for the quarter that ended in Sep. 2022 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Sep. 2022 )	/	EPS without NRI (Q: Sep. 2022 )
	=	0	/	-0.066
	=	N/A

Statera BioPharma (STU:7CB) Dividend Payout Ratio Explanation

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Statera BioPharma Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Statera BioPharma's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Statera BioPharma (STU:7CB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Statera BioPharma Inc (STU:7CB) » Definitions » Dividend Payout Ratio

Comparable Companies

Traded in Other Exchanges

N/A

Address

4333 Corbett Drive, Suite 1082, Fort Collins, CO, USA, 80525

Website

https://www.staterabiopharma.com

Statera BioPharma Inc is a pre-clinical and clinical biopharmaceutical company developing multiple product candidates to address unmet medical needs for use in diseases involving immune system dysfunction.

Statera BioPharma (STU:7CB) Headlines

No Headlines